Therapeutic drug monitoring in voriconazole-associated hyponatremia
Ren-Ai Xu1, Shuang-Li Zheng2, Li-Li Xiao2
1The Second Affiliated Hospital of Wenzhou Medical College, Wenzhou 325000, China ; The First Affiliated Hospital of Wenzhou Medical College, Wenzhou 325000, China.
Abstract:
Voriconazole is a second generation triazole antifungal agent and the first choice therapy for invasive aspergillosis (IA). Although voriconazole may be associated with many adverse events, hyponatremia has been rarely reported which potentially could result in death. Therapeutic drug monitoring (TDM) and individualization of therapy by measuring voriconazole plasma concentrations improved the efficacy and safety in patients. We report the effect of TDM to adjust voriconazole dosage in a voriconazole-related hyponatremia patient.
Related Concept Videos
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring: Drug Analysis Methods
Antihypertensive Drugs: Potassium-Sparing Diuretics
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Pharmaceutical Poisoning: Treatment Strategies


